841 related articles for article (PubMed ID: 31187794)
1. ROS-sensitive biomimetic nanocarriers modulate tumor hypoxia for synergistic photodynamic chemotherapy.
Liu H; Jiang W; Wang Q; Hang L; Wang Y; Wang Y
Biomater Sci; 2019 Aug; 7(9):3706-3716. PubMed ID: 31187794
[TBL] [Abstract][Full Text] [Related]
2. Synergistic chemo-photodynamic therapy mediated by light-activated ROS-degradable nanocarriers.
Chen Y; Gao Y; Li Y; Wang K; Zhu J
J Mater Chem B; 2019 Jan; 7(3):460-468. PubMed ID: 32254733
[TBL] [Abstract][Full Text] [Related]
3. Tumor-Penetrating Nanoparticles for Enhanced Anticancer Activity of Combined Photodynamic and Hypoxia-Activated Therapy.
Wang Y; Xie Y; Li J; Peng ZH; Sheinin Y; Zhou J; Oupický D
ACS Nano; 2017 Feb; 11(2):2227-2238. PubMed ID: 28165223
[TBL] [Abstract][Full Text] [Related]
4. Cancer-Selective Bioreductive Chemotherapy Mediated by Dual Hypoxia-Responsive Nanomedicine upon Photodynamic Therapy-Induced Hypoxia Aggravation.
Zhu R; He H; Liu Y; Cao D; Yan J; Duan S; Chen Y; Yin L
Biomacromolecules; 2019 Jul; 20(7):2649-2656. PubMed ID: 31125209
[TBL] [Abstract][Full Text] [Related]
5. Anti-LDLR modified TPZ@Ce6-PEG complexes for tumor hypoxia-targeting chemo-/radio-/photodynamic/photothermal therapy.
Song C; Xu W; Wei Z; Ou C; Wu J; Tong J; Cai Y; Dong X; Han W
J Mater Chem B; 2020 Jan; 8(4):648-654. PubMed ID: 31898718
[TBL] [Abstract][Full Text] [Related]
6. A Paclitaxel Prodrug Activatable by Irradiation in a Hypoxic Microenvironment.
Zhou S; Hu X; Xia R; Liu S; Pei Q; Chen G; Xie Z; Jing X
Angew Chem Int Ed Engl; 2020 Dec; 59(51):23198-23205. PubMed ID: 32852145
[TBL] [Abstract][Full Text] [Related]
7. An efficient delivery of photosensitizers and hypoxic prodrugs for a tumor combination therapy by membrane camouflage nanoparticles.
Wang H; Zhang C; Zhang Y; Tian R; Cheng G; Pan H; Cui M; Chang J
J Mater Chem B; 2020 Apr; 8(14):2876-2886. PubMed ID: 32191252
[TBL] [Abstract][Full Text] [Related]
8. Theranostic Liposomes with Hypoxia-Activated Prodrug to Effectively Destruct Hypoxic Tumors Post-Photodynamic Therapy.
Feng L; Cheng L; Dong Z; Tao D; Barnhart TE; Cai W; Chen M; Liu Z
ACS Nano; 2017 Jan; 11(1):927-937. PubMed ID: 28027442
[TBL] [Abstract][Full Text] [Related]
9. Supramolecular micelles as multifunctional theranostic agents for synergistic photodynamic therapy and hypoxia-activated chemotherapy.
Huang X; Chen T; Mu N; Lam HW; Sun C; Yue L; Cheng Q; Gao C; Yuan Z; Wang R
Acta Biomater; 2021 Sep; 131():483-492. PubMed ID: 34265471
[TBL] [Abstract][Full Text] [Related]
10. Novel carrier-free nanoparticles composed of 7-ethyl-10-hydroxycamptothecin and chlorin e6: Self-assembly mechanism investigation and in vitro/in vivo evaluation.
Zhao Y; Zhao Y; Ma Q; Zhang H; Liu Y; Hong J; Ding Z; Liu M; Han J
Colloids Surf B Biointerfaces; 2020 Apr; 188():110722. PubMed ID: 31887649
[TBL] [Abstract][Full Text] [Related]
11. Developing Hypoxia-Sensitive System via Designing Tumor-Targeted Fullerene-Based Photosensitizer for Multimodal Therapy of Deep Tumor.
Li L; Fu J; Ye J; Liu L; Sun Z; Wang H; Tan S; Zhen M; Wang C; Bai C
Adv Mater; 2024 Jun; 36(23):e2310875. PubMed ID: 38450765
[TBL] [Abstract][Full Text] [Related]
12. Self-Amplified pH/ROS Dual-Responsive Co-Delivery Nano-System with Chemo-Photodynamic Combination Therapy in Hepatic Carcinoma Treatment.
Huang Y; Wu S; Li J; He C; Cheng Y; Li N; Wang Y; Wu Y; Zhang J
Int J Nanomedicine; 2024; 19():3737-3751. PubMed ID: 38699684
[TBL] [Abstract][Full Text] [Related]
13. A photothermal-hypoxia sequentially activatable phase-change nanoagent for mitochondria-targeting tumor synergistic therapy.
Qu J; Teng D; Sui G; Guan S; Wang Y; Wang Q; Lin Y; Ran H; Wang Z; Wang H
Biomater Sci; 2020 Jun; 8(11):3116-3129. PubMed ID: 32352102
[TBL] [Abstract][Full Text] [Related]
14. Cascade-amplifying synergistic effects of chemo-photodynamic therapy using ROS-responsive polymeric nanocarriers.
Sun CY; Cao Z; Zhang XJ; Sun R; Yu CS; Yang X
Theranostics; 2018; 8(11):2939-2953. PubMed ID: 29896295
[TBL] [Abstract][Full Text] [Related]
15. Iodinated cyanine dye-based nanosystem for synergistic phototherapy and hypoxia-activated bioreductive therapy.
Dong Y; Zhou L; Shen Z; Ma Q; Zhao Y; Sun Y; Cao J
Drug Deliv; 2022 Dec; 29(1):238-253. PubMed ID: 35001784
[TBL] [Abstract][Full Text] [Related]
16. ROS-Responsive Selenium-Containing Carriers for Coencapsulation of Photosensitizer and Hypoxia-Activated Prodrug and Their Cellular Behaviors.
Song F; Li S; Sun C; Ji Y; Zhang Y
Macromol Biosci; 2021 Dec; 21(12):e2100229. PubMed ID: 34390189
[TBL] [Abstract][Full Text] [Related]
17. Zwitterionic Reduction-Activated Supramolecular Prodrug Nanocarriers for Photodynamic Ablation of Cancer Cells.
Zhao Y; Deng Y; Tang Z; Jin Q; Ji J
Langmuir; 2019 Feb; 35(5):1919-1926. PubMed ID: 30204452
[TBL] [Abstract][Full Text] [Related]
18. Tirapazamine-embedded polyplatinum(iv) complex: a prodrug combo for hypoxia-activated synergistic chemotherapy.
Guo D; Xu S; Yasen W; Zhang C; Shen J; Huang Y; Chen D; Zhu X
Biomater Sci; 2020 Jan; 8(2):694-701. PubMed ID: 31777870
[TBL] [Abstract][Full Text] [Related]
19. Biomimetic Decoy Inhibits Tumor Growth and Lung Metastasis by Reversing the Drawbacks of Sonodynamic Therapy.
Zhao H; Zhao B; Li L; Ding K; Xiao H; Zheng C; Sun L; Zhang Z; Wang L
Adv Healthc Mater; 2020 Jan; 9(1):e1901335. PubMed ID: 31762228
[TBL] [Abstract][Full Text] [Related]
20. Oxygen-producing catalase-based prodrug nanoparticles overcoming resistance in hypoxia-mediated chemo-photodynamic therapy.
Cheng X; He L; Xu J; Fang Q; Yang L; Xue Y; Wang X; Tang R
Acta Biomater; 2020 Aug; 112():234-249. PubMed ID: 32502633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]